title: Mechanism for activation of mutated epidermal growth factor receptors in lung cancer.
abstract: The initiation of epidermal growth factor receptor (EGFR) kinase activity proceeds via an asymmetric dimerization mechanism in which a "donor" tyrosine kinase domain (TKD) contacts an "acceptor" TKD, leading to its activation. In the context of a ligand-induced dimer, identical wild-type EGFR TKDs are thought to assume the donor or acceptor roles in a random manner. Here, we present biochemical reconstitution data demonstrating that activated EGFR mutants found in lung cancer preferentially assume the acceptor role when coexpressed with WT EGFR. Mutated EGFRs show enhanced association with WT EGFR, leading to hyperphosphorylation of the WT counterpart. Mutated EGFRs also hyperphosphorylate the related erythroblastic leukemia viral oncogene (ErbB) family member, ErbB-2, in a similar manner. This directional "superacceptor activity" is particularly pronounced in the drug-resistant L834R/T766M mutant. A 4-Å crystal structure of this mutant in the active conformation reveals an asymmetric dimer interface that is essentially the same as that in WT EGFR. Asymmetric dimer formation induces an allosteric conformational change in the acceptor subunit. Thus, superacceptor activity likely arises simply from a lower energetic cost associated with this conformational change in the mutant EGFR compared with WT, rather than from any structural alteration that impairs the donor role of the mutant. Collectively, these findings define a previously unrecognized mode of mutant-specific intermolecular regulation for ErbB receptors, knowledge of which could potentially be exploited for therapeutic benefit.
authors.affiliation: Division of Hematology/Oncology, Department of Medicine, Vanderbilt University, Nashville, TN 37232.
authors.forename: Monica
authors.initials: M
authors.lastname: Red Brewer
authors.forename: Cai-Hong
authors.initials: CH
authors.lastname: Yun
authors.forename: Darson
authors.initials: D
authors.lastname: Lai
authors.forename: Mark A
authors.initials: MA
authors.lastname: Lemmon
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Eck
authors.forename: William
authors.initials: W
authors.lastname: Pao
mesh_terms: D000818:Animals; D003460:Crystallization; D019281:Dimerization; D066246:ErbB Receptors / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism; D057809:HEK293 Cells; D006801:Humans; D015151:Immunoblotting; D047468:Immunoprecipitation; D008175:Lung Neoplasms / Q000378:metabolism*; D051379:Mice; D008958:Models, Molecular; D020125:Mutation, Missense / Q000235:genetics; D041681:NIH 3T3 Cells; D011487:Protein Conformation; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000737:chemistry / Q000378:metabolism
chemical_list: D066246:ErbB Receptors; D018719:Erb-b2 Receptor Tyrosine Kinases
keywords: TKI; WZ-4002; lapatinib; mutation
references.citation: Cancer Res. 2006 Aug 15;66(16):8163-71
references.pmid: 16912195
references.citation: FASEB J. 1989 Jan;3(1):71-5
references.pmid: 2783412
references.citation: Cancer Discov. 2013 Jan;3(1):112-23
references.pmid: 23103856
references.citation: Cell. 2010 Jun 25;141(7):1117-34
references.pmid: 20602996
references.citation: Methods Enzymol. 1997;276:307-26
references.pmid: 27754618
references.citation: Nature. 2009 Dec 24;462(7276):1070-4
references.pmid: 20033049
references.citation: Proc Natl Acad Sci U S A. 2004 Sep 7;101(36):13306-11
references.pmid: 15329413
references.citation: Science. 2004 Aug 20;305(5687):1163-7
references.pmid: 15284455
references.citation: Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
references.pmid: 20383002
references.citation: Oncogene. 2008 Aug 7;27(34):4702-11
references.pmid: 18408761
references.citation: Curr Opin Oncol. 2010 Mar;22(2):112-20
references.pmid: 19949333
references.citation: Nat Commun. 2012;3:1168
references.pmid: 23132018
references.citation: Cancer Discov. 2012 Oct;2(10):922-33
references.pmid: 22956644
references.citation: Structure. 2013 Feb 5;21(2):209-19
references.pmid: 23273428
references.citation: N Engl J Med. 2009 Sep 3;361(10):947-57
references.pmid: 19692680
references.citation: ACS Med Chem Lett. 2012 Dec 18;4(2):201-5
references.pmid: 24900643
references.citation: Proc Natl Acad Sci U S A. 2008 Feb 12;105(6):2070-5
references.pmid: 18227510
references.citation: Nat Rev Cancer. 2010 Nov;10(11):760-74
references.pmid: 20966921
references.citation: Mod Pathol. 2008 May;21 Suppl 2:S16-22
references.pmid: 18437168
references.citation: Oncogene. 2007 Oct 25;26(49):6968-78
references.pmid: 17486068
references.citation: Cancer Res. 2004 Sep 15;64(18):6652-9
references.pmid: 15374980
references.citation: Nature. 2010 Apr 22;464(7292):1218-22
references.pmid: 20376006
references.citation: Cell. 2006 Jun 16;125(6):1137-49
references.pmid: 16777603
references.citation: Cancer Res. 2008 Jan 15;68(2):571-9
references.pmid: 18199554
references.citation: Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19238-43
references.pmid: 18042729
references.citation: J Clin Invest. 2007 Dec;117(12):3846-56
references.pmid: 18060032
references.citation: Lancet Oncol. 2010 Feb;11(2):121-8
references.pmid: 20022809
references.citation: Proc Natl Acad Sci U S A. 2009 Dec 22;106(51):21608-13
references.pmid: 20007378
references.citation: Nat Rev Cancer. 2007 Mar;7(3):169-81
references.pmid: 17318210
references.citation: Cell. 2013 Jan 31;152(3):543-56
references.pmid: 23374349
references.citation: Mol Cell Biol. 1996 Oct;16(10):5276-87
references.pmid: 8816440
references.citation: Structure. 2008 Mar;16(3):460-7
references.pmid: 18334220
references.citation: Curr Opin Struct Biol. 2011 Dec;21(6):777-84
references.pmid: 21868214
references.citation: Mol Cancer Ther. 2001 Dec;1(2):85-94
references.pmid: 12467226
references.citation: Nat Struct Mol Biol. 2011 Nov 20;18(12):1388-93
references.pmid: 22101934
references.citation: Cell. 2012 May 11;149(4):860-70
references.pmid: 22579287
references.citation: PLoS Med. 2005 Mar;2(3):e73
references.pmid: 15737014
references.citation: Biochemistry. 1993 Aug 31;32(34):8742-8
references.pmid: 8395880
references.citation: Cancer Cell. 2007 Mar;11(3):217-27
references.pmid: 17349580
references.citation: Exp Cell Res. 2003 Mar 10;284(1):31-53
references.pmid: 12648464
references.citation: Nat Chem Biol. 2007 Apr;3(4):229-38
references.pmid: 17334377